Elbit Medical Technologies Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was USD 633,000 compared to USD 124.931 million a year ago. Net loss was USD 2.218 million compared to net income of USD 118.527 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to basic earnings per share from continuing operations of USD 0.58 a year ago. Diluted loss per share from continuing operations was USD 0.02 compared to diluted earnings per share from continuing operations of USD 0.36 a year ago.